Question 1

What are the potential benefits of combining DN-101 with docetaxel for my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) clinical trial (NCT00273338). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this trial compare to other treatment options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) clinical trial (NCT00273338). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this combination treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) clinical trial (NCT00273338). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) clinical trial (NCT00273338). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience complications while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) clinical trial (NCT00273338). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any travel requirements or commitments I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) clinical trial (NCT00273338). Contact the study team or your healthcare provider for specific answers.

What this study is about